Abstract
α-Receptor blockers, used to treat lower urinary tract symptoms, exert effects on areas of the body other than the prostate where α-receptors are located, including the blood vessels and the central nervous system. α-Receptors in the central and peripheral nervous system may be involved in bladder activation. α1a-Receptors are the appropriate target in men with obstructive symptoms, although α1d-receptors may also be important in patients with irritative symptoms. There is conflicting evidence about the selectivity of α-blockers. Clinical trials of these agents do not necessarily reflect results observed in animal and laboratory studies on uroselectivity. The few published comparator studies of α-blockers indicate similar efficacies, although side-effect profiles differ somewhat. Randomized, controlled studies of different α-blockers with sufficient power to detect differences in side effects between agents are needed.
Original language | English (US) |
---|---|
Pages (from-to) | 3-6 |
Number of pages | 4 |
Journal | Urology |
Volume | 59 |
Issue number | 2 SUPPL. 1 |
DOIs | |
State | Published - Feb 5 2002 |
ASJC Scopus subject areas
- Urology